By Karen Roman
Toronto-based biotech firm Radiant Biotherapeutics introduced the designation of Deborah Geraghty, Ph.D., as President and Chief Govt Officer.
The corporate additionally appointed Stefan Larson, Ph.D., as Chair of the Board of Administrators, and Ingmar Bruns, M.D., Ph.D., as Board Member, it mentioned in a press release.
Dr. Geraghty has over 20 years of economic, operational, and strategic expertise main biopharmaceutical corporations and he or she is the previous President and CEO of Anokion SA, the corporate mentioned.
Dr. Larson serves on various biotech boards together with Prilenia Therapeutics and Apnimed, whereas Dr. Bruns is Chief Medical Officer of Zentalis.
“Dr. Geraghty brings a confirmed observe report of constructing and remodeling revolutionary biotechnology corporations and we’re delighted to welcome her to Radiant,” Dr. Larson mentioned. “Her deep trade experience and strategic imaginative and prescient make her the perfect CEO to steer Radiant via this subsequent section of progress.”
READ MORE FROM HEALTHCARE EDGE
Ascentage Pharma Names CFO & SVP of Global Corporate Development & Finance
Register for our weekly publication HERE
Contact:
Click on HERE to observe us on LinkedIn
